Skip to main navigation

Angion Biomedica Corp

ANGION IS A LATE-STAGE CLINICAL COMPANY DEVELOPING SMALL MOLECULES TARGETING ACUTE ORGAN INJURY AND CHRONIC FIBROSIS

About
Our Science
- HGF/c-Met Pathway
- organ fibrosis
Pipeline
Investors
Publications
Careers
Contact
LinkedIn
Twitter

Events & Presentations

Presentations

Corporate Presentation

Current Corporate Presentation

Upcoming Events

There are no upcoming events scheduled at this time.

Archived Events

H.C. Wainwright Global Investment Conference

May 24, 2022 7:00 AM EDT

Click here for webcast

Shareholder Equity Conference

April 21, 2022 11:30 AM EDT

Click here for webcast

The Wall Street Transcript Interview

March 22, 2022

Supporting Materials

Transcript 246.1 KB

Oppenheimer 32nd Annual Healthcare Conference Fireside Chat

March 15, 2022 3:20 PM EDT

Click here for webcast

Cowen 42nd Annual Healthcare Conference

March 9, 2022 2:10 PM EST

Click here for webcast

Angion ANG-3070 in Fibrosis R&D Day

September 20, 2021 10:00 AM EDT

Click here for the replay

Angion - Investor Tools

Print Page
Email Alerts
RSS Feeds

CORPORATE ADDRESS

51 Charles Lindbergh Boulevard
Uniondale, NY 11553

Navigation

home
about
our science
pipeline
investors
publications
careers
contact

© Angion. All Rights Reserved.
Legal and Privacy Policy

SAN FRANCISCO| NEW YORK | BOSTON